Related Experiment Videos
Interleukin-13 effectively down-regulates the monocyte inflammatory potential during traumatic stress
1Department of Surgery, Ludwig-Maximilians-University, Klinikum Grosshadern, Munich, Germany.
Archives of Surgery (Chicago, Ill. : 1960)
|December 1, 1995
Summary
Interleukin-13 (IL-13) effectively reduces inflammatory responses in monocytes-macrophages (MOs) from trauma patients. This suggests IL-13 could treat trauma-induced immune deficiencies.
Area of Science:
- Immunology
- Cell Biology
- Trauma Research
Background:
- Major injuries like burns or mechanical trauma can dysregulate immune cell activity.
- Monocyte-macrophage (MO) dysfunction is implicated in post-traumatic immune deficits.
Purpose of the Study:
- To investigate the immunomodulatory potential of interleukin-13 (IL-13) on lipopolysaccharide (LPS)-stimulated human monocyte-macrophages (MOs).
- To compare the effects of IL-13 on MOs from trauma patients versus healthy controls.
Main Methods:
- Peripheral MOs were isolated from trauma patients and healthy controls at various time points post-injury.
- Cells were stimulated with LPS with or without IL-13, and inflammatory mediators were measured.
Main Results:
- LPS-stimulated MOs from trauma patients showed heightened inflammatory mediator production (TNF-α, IL-6) compared to controls.
- IL-13 significantly downregulated the synthesis of TNF-α, IL-1β, IL-6, and IL-8 in MOs from trauma patients.
- IL-13 demonstrated a similar, though slightly less potent, suppressive effect on MOs from healthy individuals.
Conclusions:
- IL-13 effectively modulates inflammatory responses in MOs, particularly those from trauma patients.
- IL-13 shows promise as a biologic response modifier for addressing trauma-induced immune deficiency.